Transforaminal epidural corticosteroïds versus shortacting anesthetic in patients with sciatica: a randomized prospective trial

Transforaminal epidural corticosteroïds versus shortacting anesthetic in patients with sciatica: a randomized prospective trial - Epidural corticosteroids in the treatment of sciatica

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON41491

Enrollment

260

Registered

2015-08-20

Start date

2016-01-13

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

radicular syndrome of lower limbs sciatica

Interventions

Intervention group 1: transforaminal epidural injection with 60 mg Depomedrol and 1,5 ml Levobupivacaine. The injection is given under radiological guidance with administration of contrast agent.

cost effectiveness

pain management

sciatica

steroid injections

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 18- 65 years old;sciatica; 8 weeks;radiologically confirmed discus;correlation between symptoms and MRI abnormalities;VAS 40 or more despite NSAIDs, PCM, of opioids

Exclusion criteria

Exclusion criteria: paresis MRC gr 3 or more, caudasyndrome;spinal surgery at the same level within 1 year ;lumbar stenosis, spondylolistesis;pregnancy;severe co morbidity (for example cancer)

Design outcomes

Primary

Measure	Time frame
Primary outcome measures: 1. Roland Disability Questionaire 2. Visual Analogue Scale (VAS) for back pain 3. Visual Analogue Scale (VAS) for leg pain 4. Global Perceived effect	—

Secondary

Measure	Time frame
Secondary outomce measures: 1. satisfaction 2. use of medication 3. absenteism from work (yes- no) 4. number of operations	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)